From 13013adb60938abd1fd4b2b4432efcb9c4cac34f Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Tue, 20 Feb 2024 12:43:08 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/STOP2030___Web___Update 2024___02.md | 6 ++++-- 1 file changed, 4 insertions(+), 2 deletions(-) diff --git a/pages/STOP2030___Web___Update 2024___02.md b/pages/STOP2030___Web___Update 2024___02.md index 074406d8..b250973a 100644 --- a/pages/STOP2030___Web___Update 2024___02.md +++ b/pages/STOP2030___Web___Update 2024___02.md @@ -101,9 +101,11 @@ - Evaluate the effectiveness of one round of [[MDA]] with [[FDC]] vs [[albendazole]] against [[Strongyloides stercolaris]] by serology - Primary goal: Safety (incidence of SAEs) - Secondary goals: - - Effectiveness at 21 days and 1 year + - Effectiveness at 21 days and 1 [[year]] - Genomic resistance - - Sample size: + - Sample [[size]]: around 20k + - Target population: School based + - Epidemiologic conditions on the sites: T - Nuestros objetivos: - Overall goal: Support the achievement of the [[WHO]] 2030 NTD Roadmap for [[STH]] and beyond - Project purpose: Advance and accelerate an innovative pharmacological tool to support the elimination goals against [[STH]] species, especially those poorly responsive to current treatment regimens \ No newline at end of file